The medical and economic burden of narcolepsy: Implications for managed care

Social Sciences

• managed care 82%
• full disability 72%
• diagnostic 61%
• early diagnosis 52%
• sleep 39%
• clinician 31%
• economics 31%
• adolescence 30%
• utilization 29%
• best practice 28%
• childhood 25%
• costs 20%
• lack 18%
• resources 15%

Medicine & Life Sciences

• Medical Economics 100%
• Narcolepsy 95%
• Managed Care Programs 83%
• Diagnostic Errors 12%
• Cataplexy 9%
• Orexins 8%
• Lateral Hypothalamic Area 8%
• Sleepiness 7%
• Muscle Weakness 7%
• Therapeutics 6%
• Nervous System Diseases 6%
• Practice Guidelines 6%
• Signs and Symptoms 5%
• Early Diagnosis 5%
• Sleep 5%
• Biomarkers 4%
• Guidelines 4%
• Costs and Cost Analysis 4%
• Neurons 4%

Business & Economics

• Managed Care 80%
• Burden 62%
• Economics 37%
• Diagnostics 22%
• Sleep 16%
• Medical Costs 16%
• Best Practice 15%
• Childhood 14%
• Resource Utilization 14%
• Adolescence 12%
• Neuron 12%
• Testing 10%
• Functioning 9%